EMILY BROWN: Open Payments
NPI 1396220810 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 33 payments from 12 companies in 2025. Trend: 2023 $485 · 2024 $372 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 8 | $188 |
| PFIZER INC. | 4 | $76 |
| Organon LLC | 5 | $75 |
| SHIELD THERAPEUTICS INC | 3 | $51 |
| Astellas Pharma US Inc | 2 | $48 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $43 |
| Exeltis, USA Inc. | 2 | $33 |
| SANOFI PASTEUR INC. | 2 | $29 |
| Smith+Nephew, Inc. | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
Products named: ZURZUVAE, ABRYSVO, NEXPLANON, ACCRUFER, Veozah, SLYND, BEYFORTUS, PICO 7.
Industry payments across KY — which companies pay providers there.
